O
Olli Polo
Researcher at University of Turku
Publications - 146
Citations - 5815
Olli Polo is an academic researcher from University of Turku. The author has contributed to research in topics: Polysomnography & Sleep apnea. The author has an hindex of 42, co-authored 140 publications receiving 5303 citations. Previous affiliations of Olli Polo include University of Tampere & Turku Centre for Computer Science.
Papers
More filters
Journal ArticleDOI
When does estrogen replacement therapy improve sleep quality
TL;DR: Alleviation of climacteric symptoms was the most important predictive factor for the beneficial effect of estrogen replacement therapy on sleep complaints and significantly diminished sleep complaints among postmenopausal women.
Journal ArticleDOI
Sleep-related disordered breathing during pregnancy in obese women.
TL;DR: Significant more sleep-related disordered breathing occurring in obese mothers than in subjects of normal weight, despite similar sleeping characteristics are shown.
Journal ArticleDOI
The effect of short-term estrogen replacement therapy on cognition: a randomized, double-blind, cross-over trial in postmenopausal women.
TL;DR: Cognitive performance decreased with age: older women were slower and made errors than younger women, and short-term estrogen replacement therapy did not provide any advantage over the placebo in terms of improving the performance.
Journal ArticleDOI
Hormones and Breathing
Tarja Saaresranta,Olli Polo +1 more
TL;DR: A number of hormones, including hypothalamic neuropeptides acting as neurotransmitters and neuromodulators in the CNS, are involved in the physiologic regulation of breathing and participate in adjustment of breathing in disease.
Journal ArticleDOI
Genome-wide association study identifies novel restless legs syndrome susceptibility loci on 2p14 and 16q12.1.
Juliane Winkelmann,Darina Czamara,Barbara Schormair,Franziska Knauf,Eva C. Schulte,Claudia Trenkwalder,Yves Dauvilliers,Olli Polo,Birgit Högl,Klaus Berger,Andrea Fuhs,Nadine Gross,Karin Stiasny-Kolster,Wolfgang H. Oertel,Cornelius G. Bachmann,Walter Paulus,Lan Xiong,Jacques Montplaisir,Guy A. Rouleau,Ingo Fietze,Jana Vavrova,David Kemlink,Karel Sonka,Sona Nevsimalova,Siong Chi Lin,Zbigniew K. Wszolek,Carles Vilariño-Güell,Matthew J. Farrer,Viola Gschliesser,Birgit Frauscher,Tina Falkenstetter,Werner Poewe,Richard P. Allen,Christopher J. Earley,William G. Ondo,Wei Dong Le,Derek Spieler,Maria Kaffe,Alexander Zimprich,Johannes Kettunen,Johannes Kettunen,Markus Perola,Markus Perola,Kaisa Silander,Kaisa Silander,Isabelle Cournu-Rebeix,Isabelle Cournu-Rebeix,Marcella Francavilla,Marcella Francavilla,Claire Fontenille,Claire Fontenille,Bertrand Fontaine,Bertrand Fontaine,Pavel Vodicka,Holger Prokisch,Peter Lichtner,Paul E. Peppard,Juliette Faraco,Emmanuel Mignot,Christian Gieger,Thomas Illig,H.-Erich Wichmann,Bertram Müller-Myhsok,Thomas Meitinger +63 more
TL;DR: Six RLS susceptibility loci of genome-wide significance are identified, two of them novel: an intergenic region on chromosome 2p14 (rs6747972), and a locus on 16q12.1 (rs3104767), a linkage disequilibrium block of 140 kb containing the 5′-end of TOX3 and the adjacent non-coding RNA BC034767.